Decibel Therapeutics Inc.

09/11/2024 | Press release | Distributed by Public on 09/10/2024 23:39

Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial